<http://webisa.webdatacommons.org/49153530>	<http://www.w3.org/ns/prov#value>	"As depicted in FIG. 4 and Tables 3, 4, 5A and 5B, and especially Table 5A and 5B, the dissolution profile of the nicotinic acid formulations of the present invention, i.e., Niaspan???, is slower than that of IR niacin, but different than that of SR niacin commercially available products." .
<http://webisa.webdatacommons.org/prov/55042921>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/49153530> .
<http://webisa.webdatacommons.org/49153530>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/54958302>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/49153530> .
<http://webisa.webdatacommons.org/49153530>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .